International randomized phase III study of elacytarabine versus investigator choice in patients with relapsed/refractory acute myeloid leukemia

Gail J. Roboz*, Todd Rosenblat, Martha Arellano, Marco Gobbi, Jessica K. Altman, Pau Montesinos, Casey O'Connell, Scott R. Solomon, Arnaud Pigneux, Norbert Vey, Robert Hills, Tove Flem Jacobsen, Athos Gianella-Borradori, Øivind Foss, Sylvia Vetrhusand, Francis J. Giles

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

104 Scopus citations

Fingerprint

Dive into the research topics of 'International randomized phase III study of elacytarabine versus investigator choice in patients with relapsed/refractory acute myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences